GLP-1 weight loss drugs linked to severe stomach paralysis and gastrointestinal injuries
Ozempic (semaglutide) and Wegovy — popular GLP-1 receptor agonist medications used for type 2 diabetes and weight loss — have been linked to serious gastrointestinal injuries including gastroparesis (stomach paralysis), severe nausea, vomiting, and intestinal obstruction.
Thousands of patients claim Novo Nordisk failed to adequately warn about the severity and permanence of these side effects. An MDL has been established in the Eastern District of Pennsylvania.
You may qualify if you took Ozempic, Wegovy, Rybelsus, or similar GLP-1 drugs and suffered severe GI complications.
Important: Active MDL — file now to preserve your rights
Is there any cost to submit my information?
No. Submitting your information is completely free. Mass tort attorneys work on a contingency fee basis — you pay nothing unless your case wins or settles.
What happens after I submit the form?
A participating law firm will review your information and contact you, typically within 24–48 hours. They'll assess your eligibility and explain your legal options at no charge.
How much compensation could I receive?
Compensation varies based on your specific circumstances, the severity of harm, and how litigation progresses. The ranges shown are estimates based on similar cases — your attorney will provide a realistic assessment.
Is it too late to file?
Statutes of limitations apply — waiting can cost you your right to compensation. Submit your information today so an attorney can assess your specific deadlines.
A participating law firm will review your information and contact you within 24–48 hours. Keep an eye on your email and phone.
Free. Unsubscribe anytime.